Home › Funds › Bellevue Group AG › SMMT

Bellevue Group AG position in SMMT

SUMMIT THERAPEUTICS INC · Health Care

Bellevue Group AG reported holding 2,113,681 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$35.7M, representing 0.74% of its reported portfolio and ranking #35 among its reported holdings. Bellevue Group AG has disclosed SMMT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.11M sh
Reported value held$35.74M
Portfolio Weight0.74%
First reportedQ3 2024
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's SMMT position evolved

Bellevue Group AG first disclosed a stake in SMMT in Q3 2024 at 10,000 shares (US$219K). The position peaked in Q3 2026 at 2,113,681 shares, worth US$35.7M. Across 9 filings, Bellevue Group AG increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,113,681 shares valued at US$35.7M — an increase of 2,098,402 shares quarter over quarter.. Notable position changes include a 1606% increase in Q4 2024 (shares rose 8% over the following quarter), a 60% trim in Q1 2025 (shares rose 10% over the following quarter), a 13734% increase in Q3 2026 (shares fell 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 10.00K $219.00K New
Q4 2024 170.59K $3.04M Add
Q1 2025 67.69K $1.31M Reduce
Q2 2025 41.74K $888.18K Reduce
Q3 2025 18.98K $392.17K Reduce
Q4 2025 14.26K $249.44K Reduce
Q1 2026 15.86K $300.67K Add
Q2 2026 15.28K $222.62K Reduce
Q3 2026 2.11M $35.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SMMT and 13F data

SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in SMMT — the largest reported positions include BAKER BROS. ADVISORS LP (US$554.4M), Kynam Capital Management, LP (US$50.7M), Affinity Asset Advisors, LLC (US$28.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SMMT

All SMMT fund holders →

FAQ

How long has Bellevue Group AG held SMMT?

Bellevue Group AG has disclosed SMMT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Bellevue Group AG's current position in SMMT?

As of Q3 2026, Bellevue Group AG holds 2.11M shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $35.74M, representing 0.74% of its reported portfolio and ranking #35.

Has Bellevue Group AG been buying or selling SMMT?

In the latest 13F filing (Q3 2026), Bellevue Group AG increased its position in SMMT. The position peaked in Q3 2026 at 2.11M shares.

Which other funds hold SMMT?

Other major institutional holders of SMMT include BAKER BROS. ADVISORS LP, Kynam Capital Management, LP, Affinity Asset Advisors, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.